RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 44.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+44.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$904M
AUM Growth
+$113M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
103
New
Increased
Reduced
Closed

Top Buys

1 +$14.7M
2 +$12.4M
3 +$9.71M
4
AXSM icon
Axsome Therapeutics
AXSM
+$9.24M
5
PRCT icon
Procept Biorobotics
PRCT
+$9.13M

Top Sells

1 +$13.9M
2 +$13.8M
3 +$11.4M
4
VRNA
Verona Pharma
VRNA
+$10.1M
5
GILD icon
Gilead Sciences
GILD
+$10M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIVN icon
76
LivaNova
LIVN
$3.39B
$2.78M 0.31%
53,000
ANNX icon
77
Annexon
ANNX
$906M
$2.51M 0.28%
823,000
+363,000
UHS icon
78
Universal Health Services
UHS
$11.4B
$2.45M 0.27%
12,000
-14,000
JANX icon
79
Janux Therapeutics
JANX
$856M
$2.45M 0.27%
100,127
+45,000
RLAY icon
80
Relay Therapeutics
RLAY
$1.91B
$2.4M 0.27%
460,000
IOVA icon
81
Iovance Biotherapeutics
IOVA
$2.14B
$2.38M 0.26%
1,097,827
+450,000
OCUL icon
82
Ocular Therapeutix
OCUL
$2.15B
$2.36M 0.26%
+202,000
KRYS icon
83
Krystal Biotech
KRYS
$7.63B
$2.07M 0.23%
11,750
-1,000
XNCR icon
84
Xencor
XNCR
$879M
$1.94M 0.22%
165,750
BTSG icon
85
BrightSpring Health Services
BTSG
$8B
$1.77M 0.2%
+60,000
MLTX icon
86
MoonLake Immunotherapeutics
MLTX
$1.32B
$1.48M 0.16%
207,000
+162,000
DNLI icon
87
Denali Therapeutics
DNLI
$3.35B
$1.45M 0.16%
100,000
STVN icon
88
Stevanato
STVN
$4.11B
$1.31M 0.15%
+51,000
IRTC icon
89
iRhythm Holdings
IRTC
$3.9B
$1.2M 0.13%
+7,000
IMCR icon
90
Immunocore
IMCR
$1.69B
$1.03M 0.11%
28,278
TECH icon
91
Bio-Techne
TECH
$8.26B
$834K 0.09%
15,000
ATEC icon
92
Alphatec Holdings
ATEC
$1.89B
$262K 0.03%
+18,000
INMB icon
93
INmune Bio
INMB
$34M
-178,284
MOH icon
94
Molina Healthcare
MOH
$7.28B
-22,200
OSCR icon
95
Oscar Health
OSCR
$3.96B
-312,092
RGEN icon
96
Repligen
RGEN
$6.86B
-19,500
VRNA
97
DELISTED
Verona Pharma
VRNA
-106,500
ALC icon
98
Alcon
ALC
$39.3B
-68,000
DXCM icon
99
DexCom
DXCM
$26.1B
-159,500
HCA icon
100
HCA Healthcare
HCA
$120B
-29,778